NCT03835624View on ClinicalTrials.gov

Interleukin 33 in Juvenile Idiopathic Arthritis Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
Juvenile Idiopathic Arthritis
Interventions
DIAGNOSTIC_TEST

interleukin 33

serum and synovial fluid samples will be obtained from patients and serum samples from controls to measure interleukin 33 and its relative mRNA expression in peripheral blood mononuclear cells by PCR

Trial Locations (1)

13518

Benha University Hospital, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT03835624 - Interleukin 33 in Juvenile Idiopathic Arthritis Patients | Biotech Hunter | Biotech Hunter